SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001562180-24-006262
Filing Date
2024-08-14
Accepted
2024-08-14 16:15:40
Documents
1
Period of Report
2024-08-12

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4  
1 PRIMARY DOCUMENT primarydocument.xml 4 6637
  Complete submission text file 0001562180-24-006262.txt   8057
Mailing Address C/O MYOKARDIA, INC. 333 ALLERTON AVE SOUTH SAN FRANCISCO CA 94080
Business Address
Semigran Marc (Reporting) CIK: 0001691494 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40236 | Film No.: 241208056

Mailing Address 1715 38TH ST BOULDER CO 80301
Business Address 1715 38TH ST BOULDER CO 80301 720-262-7002
Edgewise Therapeutics, Inc. (Issuer) CIK: 0001710072 (see all company filings)

IRS No.: 821725586 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)